Two gout experts debated whether first-line urate-lowering therapy should consist of a xanthine oxidase inhibitor or should ...
A recent study in ACR Open Rheumatology identified which patients were most likely to underreport experiencing or ...
A recent analysis of the LoDoCo2 (Low-Dose Colchicine 2) trial suggests that taking a low daily dose of colchicine may reduce ...
From the Medical Clinic, Massachusetts General Hospital, the Department of Medicine, Harvard Medical School, and the Massachusetts Department of Public Health. †Associate professor and tutor in ...
The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...
Scilex Holding (NASDAQ:SCLX – Get Free Report) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 5,280,000 shares, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback